Valeant Pharma (VRX) Sinks 27% in Pre-Open Trade, Falling Below $14

November 8, 2016 8:56 AM EST

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Valeant Pharma (NYSE: VRX) is free-fall pre-open. Shares are down 27% to $13.92.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Short Sales, Trader Talk

Related Entities

Pre Market Movers

Add Your Comment